BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9330413)

  • 1. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis.
    Grasemann H; Michler E; Wallot M; Ratjen F
    Pediatr Pulmonol; 1997 Sep; 24(3):173-7. PubMed ID: 9330413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath sulfides and pulmonary function in cystic fibrosis.
    Kamboures MA; Blake DR; Cooper DM; Newcomb RL; Barker M; Larson JK; Meinardi S; Nussbaum E; Rowland FS
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15762-7. PubMed ID: 16247007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.
    Chapman AL; Morrissey BM; Vasu VT; Juarez MM; Houghton JS; Li CS; Cross CE; Eiserich JP
    J Cyst Fibros; 2010 Mar; 9(2):84-92. PubMed ID: 20080069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of nitric oxide concentrations in exhaled air from the airways in allergic rhinitis patients.
    Kłak A; Krzych-Fałta E; Samoliński BK; Zalewska M
    Postepy Dermatol Alergol; 2016 Apr; 33(2):87-95. PubMed ID: 27279816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vest Chest Physiotherapy Airway Clearance is Associated with Nitric Oxide Metabolism.
    Sisson JH; Wyatt TA; Pavlik JA; Sarna PS; Murphy PJ
    Pulm Med; 2013; 2013():291375. PubMed ID: 24349778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of COVID-19 on the Oral Bacterial Flora in Patients Wearing Complete Dentures and on the Level of Exhaled Nitric Oxide as a Marker of Inflammation.
    Wyszyńska M; Czelakowska A; Rosak P; Kasperski J; Łopacińska M; Ghanem A; Mertas A; Skucha-Nowak M
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantity of Carbonic Acid Exhaled by Man in Health and Disease.
    West J Med Surg; 1849 Jun; 3(6):537-539. PubMed ID: 38209515
    [No Abstract]   [Full Text] [Related]  

  • 8. Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.
    Anidi IU; Olivier KN
    Clin Chest Med; 2023 Dec; 44(4):839-845. PubMed ID: 37890920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Nitric Oxide Synthetase Activity in Primary Ciliary Dyskinesia-Data-Driven Hypothesis.
    Eggenkemper L; Schlegtendal A; Maier C; Lücke T; Brinkmann F; Beckmann B; Tsikas D; Koerner-Rettberg C
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections.
    Cogen JD; Nichols DP; Goss CH; Somayaji R
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S32-S39. PubMed ID: 36069901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial.
    Trimble A; Zeman K; Wu J; Ceppe A; Bennett W; Donaldson S
    PLoS One; 2022; 17(5):e0268622. PubMed ID: 35594286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule Akt-activation in airway cells induces NO production and reduces IL-8 transcription through Nrf-2.
    Gopallawa I; Kuek LE; Adappa ND; Palmer JN; Lee RJ
    Respir Res; 2021 Oct; 22(1):267. PubMed ID: 34666758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Molecular Therapeutic Agents and Drug Candidates for
    Quang NT; Jang J
    Front Pharmacol; 2021; 12():724725. PubMed ID: 34526902
    [No Abstract]   [Full Text] [Related]  

  • 14. NO donors and NO delivery methods for controlling biofilms in chronic lung infections.
    Cai YM; Zhang YD; Yang L
    Appl Microbiol Biotechnol; 2021 May; 105(10):3931-3954. PubMed ID: 33937932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine Therapy for Lung Diseases.
    Scott JA; Maarsingh H; Holguin F; Grasemann H
    Front Pharmacol; 2021; 12():627503. PubMed ID: 33833679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases.
    Magallón M; Pastor S; Carrión AE; Bañuls L; Pellicer D; Castillo S; Bondía S; Navarro-García MM; González C; Dasí F
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of the Transport and Exchange of a Gas Species in Lungs With an Asymmetric Branching Pattern. Application to Nitric Oxide.
    Buess A; Van Muylem A; Nonclercq A; Haut B
    Front Physiol; 2020; 11():570015. PubMed ID: 33362572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.
    Checa J; Aran JM
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of high-dose nitric oxide against pulmonary
    Bogdanovski K; Chau T; Robinson CJ; MacDonald SD; Peterson AM; Mashek CM; Wallin WA; Rimkus M; Montgomery F; Lucas da Silva J; Gupta S; Ghaffari A; Zelazny AM; Olivier KN
    Access Microbiol; 2020; 2(9):acmi000154. PubMed ID: 33195983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.
    Ahmadi S; Xia S; Wu YS; Di Paola M; Kissoon R; Luk C; Lin F; Du K; Rommens J; Bear CE
    Elife; 2018 Jul; 7():. PubMed ID: 30004386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.